Virtual Medicinal Product (VMP) - Alendronic acid 35mg/5ml oral solution
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Alendronic acid 35mg/5ml oral solution | Start Date 01-07-2009 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral solution
- Ontology Form/Route
- solution.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- M05BA04
- BNF Codes
-
- BNF code 06060200
| Code | Start Date | End Date |
|---|---|---|
| 15631411000001101 | 01-07-2009 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Alendronate sodium | Based on Base Substance | Alendronic acid | 7 mg | 1 ml |
Name
Alendronate sodium
Basis of strength description
Based on Base Substance
BOSS
Alendronic acid
Strength and UOM (Nmr)
7
Strength and UOM (Dmr)
1
Parent Products
-
VTMAlendronic acid
-
VMP(Current) Alendronic acid 35mg/5ml oral solution
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |